GlassScriptPhysician profile
Gerald Zemel
NPI 1770542854
$1,332.74
in general payments reported to CMS, 2019-2025
22 companies · $99.75 in 2025
The $99.75 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $176 · 2021: $79.05 · 2022: $220 · 2023: $23.19 · 2024: $74.64 · 2025: $99.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $333.92 | 2019-2024 | Gore Viabahn Endoprosthesis With Heparin |
| Sirtex Medical INC | $179.47 | 2020-2022 | |
| Medtronic USA, INC. | $164.10 | 2019 | |
| Medtronic, INC. | $121.41 | 2021-2025 | Osteocool Rf Ablation System |
| Cook Medical LLC | $120.03 | 2019 | |
| Bard Peripheral Vascular, INC. | $107.00 | 2020 | |
| Clovis Oncology, INC. | $31.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $31.78 | 2021-2024 | Tagrisso |
| Ge Healthcare | $26.81 | 2022 | |
| Janssen Scientific Affairs, LLC | $24.96 | 2019 | |
| Eisai INC. | $23.19 | 2023 | |
| Blueprint Medicines Corporation | $21.79 | 2024 | Ayvakit |
| Delcath Systems | $21.26 | 2025 | Hepzato Kit |
| Ethicon US, LLC | $18.31 | 2021 | |
| Tg Therapeutics, INC. | $17.13 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $16.51 | 2019 | |
| Boston Scientific Corporation | $16.37 | 2019 | |
| Mozarc Medical US LLC | $15.62 | 2025 | Palindrome |
| Cardiva Medical, INC. | $13.21 | 2019 | |
| Octapharma USA, INC. | $12.01 | 2020 | |
| Shockwave Medical, INC | $10.85 | 2019 | |
| Penumbra, INC. | $5.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Zemel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.